,text,position,name,last,events,dateString,collapsed,checked
0,"<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>
<p><a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",0,Application Received,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Apr 2022', 'fs': 'Apr 2022', 'change': None}, 'Event_Description': {'s': 'Application received', 'fs': 'Application received', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywM2AR'}, 'Id': 'a0POZ00000ArywM2AR', 'Event_Date__c': '2022-04-06', 'Event_Description__c': 'Application received', 'Stage__c': 'Application Received', 'Formatted_Date__c': 'Apr 2022', 'Status_History__c': 'a132P000000DxciQAC'}, 'change': None}]",Apr 2022,False,True
1,"<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/"" rel=""nofollow"">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/"" rel=""nofollow"">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>
<p style=""height: 20px"">&nbsp;</p>
<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>
<p style=""height: 15px"">&nbsp;</p>
<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>
<p style=""height: 20px"">&nbsp;</p>
<p><a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/"" rel=""nofollow"">PTAC</a>  and <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//"" rel=""nofollow"">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",1,Seeking Clinical Advice,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Apr 2022', 'fs': 'Apr 2022', 'change': None}, 'Event_Description': {'s': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Monday 9 May 2022', 'fs': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Monday 9 May 2022', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywN2AR'}, 'Id': 'a0POZ00000ArywN2AR', 'Event_Date__c': '2022-04-20', 'Event_Description__c': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Monday 9 May 2022', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Apr 2022', 'Status_History__c': 'a132P000000DxqbQAC'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Aug 2022', 'fs': 'Aug 2022', 'change': None}, 'Event_Description': {'s': 'Clinical advice required', 'fs': 'Clinical advice required', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywO2AR'}, 'Id': 'a0POZ00000ArywO2AR', 'Event_Date__c': '2022-08-03', 'Event_Description__c': 'Clinical advice required', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Aug 2022', 'Status_History__c': 'a132P000000DxcsQAC'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': 'No Formal Recommendation', 'fs': 'No Formal Recommendation', 'change': None}, 'Links': {'s': '<p><a href=""https://pharmac.govt.nz/assets/2022-05-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">2022-05-Immunisation-Advisory-Committee-Record.pdf (pharmac.govt.nz)</a></p>', 'fs': '<p><a href=""https://pharmac.govt.nz/assets/2022-05-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">2022-05-Immunisation-Advisory-Committee-Record.pdf (pharmac.govt.nz)</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Sep 2022', 'fs': 'Sep 2022', 'change': None}, 'Event_Description': {'s': 'Clinical advice received from Immunisation Advisory Committee at meeting Monday 9 May 2022.', 'fs': 'Clinical advice received from Immunisation Advisory Committee at meeting Monday 9 May 2022.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywP2AR'}, 'Id': 'a0POZ00000ArywP2AR', 'Event_Date__c': '2022-09-30', 'Event_Description__c': 'Clinical advice received from Immunisation Advisory Committee at meeting Monday 9 May 2022.', 'Stage__c': 'Seeking Clinical Advice', 'Links__c': '<p><a href=""https://pharmac.govt.nz/assets/2022-05-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">2022-05-Immunisation-Advisory-Committee-Record.pdf (pharmac.govt.nz)</a></p>', 'Outcome__c': 'No Formal Recommendation', 'Formatted_Date__c': 'Sep 2022', 'Status_History__c': 'a132P000000E5mxQAC'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Jan 2023', 'fs': 'Jan 2023', 'change': None}, 'Event_Description': {'s': 'Clinical advice required', 'fs': 'Clinical advice required', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywQ2AR'}, 'Id': 'a0POZ00000ArywQ2AR', 'Event_Date__c': '2023-01-19', 'Event_Description__c': 'Clinical advice required', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Jan 2023', 'Status_History__c': 'a132P000000EDINQA4'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Nov 2023', 'fs': 'Nov 2023', 'change': None}, 'Event_Description': {'s': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Thursday 9 November 2023', 'fs': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Thursday 9 November 2023', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywR2AR'}, 'Id': 'a0POZ00000ArywR2AR', 'Event_Date__c': '2023-11-02', 'Event_Description__c': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Thursday 9 November 2023', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Nov 2023', 'Status_History__c': 'a13OZ000003nSMUYA2'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Feb 2024', 'fs': 'Feb 2024', 'change': None}, 'Event_Description': {'s': 'Clinical advice required', 'fs': 'Clinical advice required', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywS2AR'}, 'Id': 'a0POZ00000ArywS2AR', 'Event_Date__c': '2024-02-01', 'Event_Description__c': 'Clinical advice required', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Feb 2024', 'Status_History__c': 'a13OZ00000CVvEQYA1'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2024', 'fs': 'Mar 2024', 'change': None}, 'Event_Description': {'s': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Tuesday 26 March 2024', 'fs': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Tuesday 26 March 2024', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywW2AR'}, 'Id': 'a0POZ00000ArywW2AR', 'Event_Date__c': '2024-03-20', 'Event_Description__c': 'Assigned to Immunisation Advisory Committee meeting to provide advice on Tuesday 26 March 2024', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Mar 2024', 'Status_History__c': 'a13OZ00000CVxGEYA1'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': '<p>The Advisory Committee recommended that the RVZV vaccine eligibility criteria be widened with <strong>high priority</strong> to include people aged 18 years and older who are immunocompromised, within the context of vaccines and immunisations subject to Special Authority criteria.</p><p>\xa0</p><p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf#page16"" target=""_blank"">Link to relevant discussion within the meeting record.</a></p>', 'fs': '<p>The Advisory Committee recommended that the RVZV vaccine eligibility criteria be widened with <strong>high priority</strong> to include people aged 18 years and older who are immunocompromised, within the context of vaccines and immunisations subject to Special Authority criteria.</p><p>\xa0</p><p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf#page16"" target=""_blank"">Link to relevant discussion within the meeting record.</a></p>', 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': 'High', 'fs': 'High', 'change': None}, 'Links': {'s': '<p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to meeting record.</a></p>', 'fs': '<p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to meeting record.</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Mar 2024', 'fs': 'Mar 2024', 'change': None}, 'Event_Description': {'s': 'Clinical advice received from Immunisation Advisory Committee at meeting Thursday 9 November 2023.', 'fs': 'Clinical advice received from Immunisation Advisory Committee at meeting Thursday 9 November 2023.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywY2AR'}, 'Id': 'a0POZ00000ArywY2AR', 'Event_Date__c': '2024-03-28', 'Event_Description__c': 'Clinical advice received from Immunisation Advisory Committee at meeting Thursday 9 November 2023.', 'Stage__c': 'Seeking Clinical Advice', 'Links__c': '<p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to meeting record.</a></p>', 'Outcome__c': 'High', 'Formatted_Date__c': 'Mar 2024', 'Published_Recommendation__c': '<p>The Advisory Committee recommended that the RVZV vaccine eligibility criteria be widened with <strong>high priority</strong> to include people aged 18 years and older who are immunocompromised, within the context of vaccines and immunisations subject to Special Authority criteria.</p><p>\xa0</p><p><a href=""https://pharmac.govt.nz/assets/2023-11-09-Immunisation-Advisory-Committee-Record.pdf#page16"" target=""_blank"">Link to relevant discussion within the meeting record.</a></p>', 'Status_History__c': 'a13OZ000008ox3WYAQ'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': '<p>The Committee recommended the access criteria for recombinant varicella zoster virus vaccine for the prevention of shingles be amended provisionally. </p><p><br></p><p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf#page=6"" target=""_blank"">Link to the relevant discussion within the meeting record.</a></p>', 'fs': '<p>The Committee recommended the access criteria for recombinant varicella zoster virus vaccine for the prevention of shingles be amended provisionally. </p><p><br></p><p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf#page=6"" target=""_blank"">Link to the relevant discussion within the meeting record.</a></p>', 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': 'No Formal Recommendation', 'fs': 'No Formal Recommendation', 'change': None}, 'Links': {'s': '<p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to the Meeting Record.</a></p>', 'fs': '<p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to the Meeting Record.</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Jul 2024', 'fs': 'Jul 2024', 'change': None}, 'Event_Description': {'s': 'Clinical advice received from Immunisation Advisory Committee at meeting Tuesday 26 March 2024.', 'fs': 'Clinical advice received from Immunisation Advisory Committee at meeting Tuesday 26 March 2024.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000Arywa2AB'}, 'Id': 'a0POZ00000Arywa2AB', 'Event_Date__c': '2024-07-24', 'Event_Description__c': 'Clinical advice received from Immunisation Advisory Committee at meeting Tuesday 26 March 2024.', 'Stage__c': 'Seeking Clinical Advice', 'Links__c': '<p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf"" target=""_blank"">Link to the Meeting Record.</a></p>', 'Outcome__c': 'No Formal Recommendation', 'Formatted_Date__c': 'Jul 2024', 'Published_Recommendation__c': '<p>The Committee recommended the access criteria for recombinant varicella zoster virus vaccine for the prevention of shingles be amended provisionally. </p><p><br></p><p><a href=""https://pharmac.govt.nz/assets/2024-03-26-Immunisation-Advisory-Committee-Record.pdf#page=6"" target=""_blank"">Link to the relevant discussion within the meeting record.</a></p>', 'Status_History__c': 'a13OZ00000CVs28YAD'}, 'change': None}]",Apr 2022,False,True
2,"<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/"" rel=""nofollow"">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>
<p>&nbsp;</p>
<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>
<ul>
<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>
<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>
<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>
</ul>
<p>&nbsp;</p>
<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",2,Under Assessment,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2024', 'fs': 'Mar 2024', 'change': None}, 'Event_Description': {'s': 'Working to compare options', 'fs': 'Working to compare options', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywV2AR'}, 'Id': 'a0POZ00000ArywV2AR', 'Event_Date__c': '2024-03-13', 'Event_Description__c': 'Working to compare options', 'Stage__c': 'Under Assessment', 'Formatted_Date__c': 'Mar 2024', 'Status_History__c': 'a13OZ000007tSamYAE'}, 'change': None}]",Mar 2024,False,True
3,"<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmacâ€™s decision-making process.</p>
<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>
<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>
<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",3,Options Compared,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2024', 'fs': 'Mar 2024', 'change': None}, 'Event_Description': {'s': 'The relative ranking of the pharmaceutical application has been completed.', 'fs': 'The relative ranking of the pharmaceutical application has been completed.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywX2AR'}, 'Id': 'a0POZ00000ArywX2AR', 'Event_Date__c': '2024-03-25', 'Event_Description__c': 'The relative ranking of the pharmaceutical application has been completed.', 'Stage__c': 'Options Compared', 'Formatted_Date__c': 'Mar 2024', 'Status_History__c': 'a13OZ000008JYskYAG'}, 'change': None}]",Mar 2024,False,True
4,"<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>
<p><a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",4,Under Consultation,False,"[{'Summary': {'s': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"" style=""font-size: 14px; background-color: rgb(255, 255, 255);"">Consultation Letter</a></p>', 'fs': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"" style=""font-size: 14px; background-color: rgb(255, 255, 255);"">Consultation Letter</a></p>', 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Feb 2024', 'fs': 'Feb 2024', 'change': None}, 'Event_Description': {'s': 'Public consultation for this application is active.', 'fs': 'Public consultation for this application is active.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywT2AR'}, 'Id': 'a0POZ00000ArywT2AR', 'Event_Date__c': '2024-02-15', 'Event_Description__c': 'Public consultation for this application is active.', 'Stage__c': 'Under Consultation', 'Summary__c': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"" style=""font-size: 14px; background-color: rgb(255, 255, 255);"">Consultation Letter</a></p>', 'Formatted_Date__c': 'Feb 2024', 'Status_History__c': 'a13OZ000008OTh0YAG'}, 'change': None}]",Feb 2024,False,True
5,"<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",5,Reviewing Consultation Feedback,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Feb 2024', 'fs': 'Feb 2024', 'change': None}, 'Event_Description': {'s': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'fs': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywU2AR'}, 'Id': 'a0POZ00000ArywU2AR', 'Event_Date__c': '2024-02-29', 'Event_Description__c': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'Stage__c': 'Reviewing Consultation Feedback', 'Formatted_Date__c': 'Feb 2024', 'Status_History__c': 'a13OZ000008Oak5YAC'}, 'change': None}]",Feb 2024,False,True
6,"<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>
<p>We consider and assess all funding decisions using the&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc"" rel=""nofollow"">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>
<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>
<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>
<p>&nbsp;</p>",6,Decision,True,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"">Notification letter</a></p>', 'fs': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"">Notification letter</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Apr 2024', 'fs': 'Apr 2024', 'change': None}, 'Event_Description': {'s': 'The funding application has been approved.', 'fs': 'The funding application has been approved.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000ArywZ2AR'}, 'Id': 'a0POZ00000ArywZ2AR', 'Event_Date__c': '2024-04-16', 'Event_Description__c': 'The funding application has been approved.', 'Stage__c': 'Decision', 'Links__c': '<p><a href=""https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-treatments-for-ovarian-cancer-respiratory-disorders-infectious-diseases-and-vasculitis"" target=""_blank"">Notification letter</a></p>', 'Formatted_Date__c': 'Apr 2024', 'Status_History__c': 'a13OZ0000091IDuYAM'}, 'change': None}]",Apr 2024,False,True
